Imidazo[1,2-a]pyridine Scaffold as Prospective Therapeutic Agents.

Curr Top Med Chem

Department of Pharmaceutical Chemistry, School of Pharmacy, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia.

Published: February 2017

Imidazo[1,2-a]pyridine is one of the most potential bicyclic 5-6 heterocyclic rings that is recognized as a "drug prejudice" scaffold due to its broad range of applications in medicinal chemistry such as anticancer, antimycobacterial, antileishmanial, anticonvulsant, antimicrobial, antiviral, antidiabetic, proton pump inhibitor, insecticidal activities. This scaffold has also been represented in various marketed preparations such as zolimidine, zolpidem, alpidem. Therefore, several attempts were made to carry out the structural modifications of this scaffold to discover and develop novel therapeutic agents. This review provides a valuable insight into the research findings of wide range of derivatives of imidazo[1,2-a]pyridine scaffold leading to promising heterocyclic compounds which could be explored further for the synthesis of new derivatives as well as construction of potential drug-like chemical libraries for biological screening in search of new therapeutic agents.

Download full-text PDF

Source
http://dx.doi.org/10.2174/1568026616666160530153233DOI Listing

Publication Analysis

Top Keywords

therapeutic agents
12
imidazo[12-a]pyridine scaffold
8
scaffold prospective
4
prospective therapeutic
4
agents imidazo[12-a]pyridine
4
imidazo[12-a]pyridine potential
4
potential bicyclic
4
bicyclic 5-6
4
5-6 heterocyclic
4
heterocyclic rings
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!